Literature DB >> 19108619

Production of a monoclonal antibody against non-structural protein 3 of dengue-2 virus by intrasplenic injection.

Zongtao Chen1, Yanping Tian, Limei Liu, Jing An.   

Abstract

Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are highly infectious diseases caused by dengue virus (DV). DV non-structural protein 3 (NS3) is known to possess ATPase, helicase, and protease activity that is a constitutive part of the replication complex of DV. In this study, we discuss the cloning, expression, and purification of the DV-2 NS3 protein to immunize mice by intrasplenic injection and then to generate a monoclonal antibody (MAb). One MAb, named 4F5, was obtained and it was specific to NS3 of DV-2. Immunofluorescence show that 4F5 recognizes the native protein in infected ECV304 cells. Likewise, C6/36-infected lysates were used in Western blot analysis, and we observed the specific characteristic band that defines NS3. We conclude that MAb 4F5 may be a useful tool, not only to study the replicative process of DV, but also to generate specific diagnostic tools for DV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108619     DOI: 10.1089/hyb.2008.0048

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  3 in total

1.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

2.  High affinity human antibody fragments to dengue virus non-structural protein 3.

Authors:  Nicole J Moreland; Moon Y F Tay; Elfin Lim; Prasad N Paradkar; Danny N P Doan; Yin Hoe Yau; Susana Geifman Shochat; Subhash G Vasudevan
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

3.  Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study.

Authors:  Mohammad Albanghali; Saleh Alghamdi; Mohammed Alzahrani; Bassant Barakat; Abdul Haseeb; Jonaid Ahmad Malik; Sakeel Ahmed; Sirajudheen Anwar
Journal:  J Infect Public Health       Date:  2022-02-03       Impact factor: 3.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.